- |||||||||| Litx (talaporfin) / Light Sciences Oncology
Trial completion: Phase 3 Trial of Litx (clinicaltrials.gov) - Nov 13, 2012 P3, N=483, Completed, Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||||||| 5-fluorouracil / Generic mfg., cisplatin / Generic mfg., docetaxel / Generic mfg.
Biomarker, New P2 trial, Metastases: Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. (clinicaltrials.gov) - Oct 24, 2012 P2, N=127, Recruiting,
- |||||||||| Cyramza (ramucirumab) / Eli Lilly
Enrollment closed, Metastases: A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer (clinicaltrials.gov) - Sep 27, 2012 P2, N=166, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., cisplatin / Generic mfg.
Trial termination, Surgery, Metastases: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer (clinicaltrials.gov) - Sep 19, 2012 P3, N=144, Terminated, Active, not recruiting --> Terminated; low accrual Active, not recruiting --> Terminated; low accrual
- |||||||||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Trial completion, Combination therapy, Metastases: Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Sep 19, 2012 P3, N=430, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
Biomarker, Trial completion, Metastases: Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Sep 17, 2012 P2, N=33, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Avastin (bevacizumab) / Roche, parsatuzumab (RG7414) / Roche
Enrollment closed, Combination therapy, Metastases: A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer (clinicaltrials.gov) - Sep 5, 2012 P2, N=128, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
|